EVALUATION OF ANEMIA IN PREGNANCY: PREVALENCE, RISK FACTORS, AND CLINICAL OUTCOMES
Abstract
Anemia during pregnancy remains a major public health concern, particularly in low- and middle-income countries. It is associated with increased maternal and fetal morbidity. This study aims to determine the prevalence of anemia among pregnant women, identify associated risk factors, and assess its impact on pregnancy outcomes.
Keywords
Anemia, Pregnancy, Hemoglobin, Maternal health, Obstetric outcomes
References
- World Health Organization. (2012). Guideline: Daily iron and folic acid supplementation in pregnant women. Geneva: WHO.
- Balarajan, Y., Ramakrishnan, U., Özaltin, E., Shankar, A. H., & Subramanian, S. V. (2011). Anaemia in low-income and middle-income countries. The Lancet, 378(9809), 2123–2135. https://doi.org/10.1016/S0140-6736(10)62304-5
- Milman, N. (2008). Prepartum anaemia: prevention and treatment. Annals of Hematology, 87(12), 949–959.
- Pena-Rosas, J. P., & Viteri, F. E. (2009). Effects and safety of preventive oral iron or iron+ folic acid supplementation for women during pregnancy. Cochrane Database of Systematic Reviews, (4).
- Kumar, K. J., Asha, N., Murthy, D. S., Sujatha, M. S., & Manjunath, V. G. (2013). Maternal anemia in various trimesters and its effect on newborn weight and maturity: An observational study. International Journal of Preventive Medicine, 4(2), 193–199.
Downloads
Download data is not yet available.